Amesite Inc. (AMST) stock
AMSTNasdaqServices-Prepackaged SoftwareFiscal year ends June 30
Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 10/3028% below fair value
$0.47−0.00 (-0.77%)
Close on Nov 13, 2026Market cap $3.11MP/E –Yield –
Amesite r&d expenses
Research and development expenses are spending on new products and technology.
Amesite's R&D Expenses for the twelve months ending Sep 30, 2026 was $698.82K, up 6.8% year over year. For fiscal 2026 it was $613.58K, down 11.2% from the year before. The highest annual figure on record is $3.06M in fiscal 2022.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | $613.58K | -11.2% |
| FY2025 | Jun 30, 2025 | $691.15K | -35.7% |
| FY2024 | Jun 30, 2024 | $1.07M | -29.5% |
| FY2023 | Jun 30, 2023 | $1.52M | -50.2% |
| FY2022 | Jun 30, 2022 | $3.06M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ3 2026 | Sep 30, 2026 | $188.13K | +82.9% |
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | $211.65K | +26.3% |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | $134.19K | -22.0% |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | $164.85K | -22.2% |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | $102.89K | -26.3% |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | $167.53K | -9.8% |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | $172.10K | -23.1% |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | $211.87K | -36.0% |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | $139.66K | -58.1% |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | $185.83K | – |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | $223.85K | – |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | $331.22K | – |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | $333.43K | – |
See a number that looks wrong?